Published in Biochem J on September 15, 2007
The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab (2009) 2.39
Lipid metabolism and toxicity in the heart. Cell Metab (2012) 1.71
Tauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular Ca2+ anomalies. PLoS One (2013) 1.44
Adaptation and maladaptation of the heart in obesity. Hypertension (2008) 1.29
Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. J Biol Chem (2009) 1.24
A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res Cardiol (2011) 1.19
Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol (2008) 1.16
Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities. Am J Physiol Regul Integr Comp Physiol (2011) 1.12
Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol (2009) 1.09
Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection. J Mol Cell Cardiol (2010) 1.07
Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J Lipid Res (2010) 1.04
UCP3 regulates cardiac efficiency and mitochondrial coupling in high fat-fed mice but not in leptin-deficient mice. Diabetes (2012) 1.03
The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. Am J Physiol Heart Circ Physiol (2010) 1.01
Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res (2012) 1.00
Differential effects of hypothalamic long-chain fatty acid infusions on suppression of hepatic glucose production. Am J Physiol Endocrinol Metab (2010) 1.00
Taking pressure off the heart: the ins and outs of atrophic remodelling. Cardiovasc Res (2011) 0.98
Mechanisms of lipotoxicity in the cardiovascular system. Curr Hypertens Rep (2012) 0.98
Interaction of diet and diabetes on cardiovascular function in rats. Am J Physiol Heart Circ Physiol (2008) 0.96
Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPARα/PGC1α signaling. PLoS One (2012) 0.95
Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a high-fat "Western" diet. Obesity (Silver Spring) (2010) 0.93
Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab (2008) 0.92
Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS One (2009) 0.90
Chronic ingestion of a Western diet increases O-linked-β-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart. Life Sci (2012) 0.89
Obesogenic high fat western diet induces oxidative stress and apoptosis in rat heart. Mol Cell Biochem (2010) 0.89
Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance. PLoS One (2012) 0.88
Rapid inhibition of pyruvate dehydrogenase: an initiating event in high dietary fat-induced loss of metabolic flexibility in the heart. PLoS One (2013) 0.88
Hearts from mice fed a non-obesogenic high-fat diet exhibit changes in their oxidative state, calcium and mitochondria in parallel with increased susceptibility to reperfusion injury. PLoS One (2014) 0.86
High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury. Cardiovasc Diabetol (2014) 0.85
Cardiac insulin resistance and microRNA modulators. Exp Diabetes Res (2011) 0.84
The complexities of diabetic cardiomyopathy: lessons from patients and animal models. Curr Diab Rep (2008) 0.84
Metabolic stress in the myocardium: adaptations of gene expression. J Mol Cell Cardiol (2012) 0.84
Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration. BMC Cardiovasc Disord (2014) 0.83
Influence of dark phase restricted high fat feeding on myocardial adaptation in mice. J Mol Cell Cardiol (2012) 0.83
Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol Metab (2015) 0.82
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. Dis Model Mech (2012) 0.82
Maternal metabolic perturbations elicited by high-fat diet promote Wnt-1-induced mammary tumor risk in adult female offspring via long-term effects on mammary and systemic phenotypes. Carcinogenesis (2014) 0.81
In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy. Cardiovasc Res (2015) 0.80
Nutrient sensing and utilization: Getting to the heart of metabolic flexibility. Biochimie (2015) 0.79
Chronic high-fat diet-induced obesity decreased survival and increased hypertrophy of rats with experimental eccentric hypertrophy from chronic aortic regurgitation. BMC Cardiovasc Disord (2014) 0.79
A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study. J Clin Endocrinol Metab (2015) 0.79
Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet. Cardiovasc Diabetol (2015) 0.79
Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling. Nutr Diabetes (2013) 0.78
Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts. Am J Physiol Regul Integr Comp Physiol (2014) 0.78
Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats. PLoS One (2012) 0.78
Estrogen receptor alpha activation enhances mitochondrial function and systemic metabolism in high-fat-fed ovariectomized mice. Physiol Rep (2016) 0.77
Cardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux. Biochim Biophys Acta (2011) 0.77
Cardioprotective effects of dietary lipids evident in the time-dependent alterations of cardiac function and gene expression following myocardial infarction. Physiol Rep (2014) 0.77
The role of dietary fatty acids in predicting myocardial structure in fat-fed rats. Lipids Health Dis (2011) 0.77
Metabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice. Endocr Relat Cancer (2016) 0.76
High-Fat Diet Promotion of Endometriosis in an Immunocompetent Mouse Model is Associated With Altered Peripheral and Ectopic Lesion Redox and Inflammatory Status. Endocrinology (2016) 0.75
Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling. Nutr Metab (Lond) (2016) 0.75
Obesity and cardiac metabolism in women. JACC Cardiovasc Imaging (2008) 0.75
Dietary fatty acids alter left ventricular myocardial gene expression in Wistar rats. Nutr Res (2014) 0.75
Classification of different degrees of adiposity in sedentary rats. Braz J Med Biol Res (2016) 0.75
Brain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus. Front Neurosci (2017) 0.75
Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistance. Cell Stress Chaperones (2015) 0.75
Diastolic Dysfunction Induced by a High-Fat Diet Is Associated with Mitochondrial Abnormality and Adenosine Triphosphate Levels in Rats. Endocrinol Metab (Seoul) (2015) 0.75
Effects of olive oil and its minor phenolic constituents on obesity-induced cardiac metabolic changes. Nutr J (2010) 0.75
Effects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki Rats. Gene Regul Syst Bio (2017) 0.75
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 16.71
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol (1990) 8.97
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A (2000) 5.65
Superoxide activates mitochondrial uncoupling proteins. Nature (2002) 5.43
Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem (2005) 4.30
Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation (2005) 3.22
Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol (2004) 2.97
Utilization of energy-providing substrates in the isolated working rat heart. Biochem J (1980) 2.94
A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A (2003) 2.68
Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation (2002) 2.61
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology (2005) 2.43
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes (2004) 2.39
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes (2005) 2.33
PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med (2000) 2.19
Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation (2002) 2.14
Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med (1998) 2.12
Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest (2000) 2.12
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res (2001) 1.88
Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem (1998) 1.85
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes (2002) 1.83
Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem (2006) 1.77
The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J Biol Chem (2001) 1.69
Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J (2001) 1.68
Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) (2006) 1.53
Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun (2001) 1.50
Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am J Physiol Heart Circ Physiol (2006) 1.41
Uncoupling protein-3: clues in an ongoing mitochondrial mystery. FASEB J (2007) 1.38
Metabolic energetics and genetics in the heart. Ann N Y Acad Sci (2005) 1.35
Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell. J Biol Chem (2000) 1.29
Fatty acids as natural uncouplers preventing generation of O2.- and H2O2 by mitochondria in the resting state. FEBS Lett (1998) 1.24
Diabetes or peroxisome proliferator-activated receptor alpha agonist increases mitochondrial thioesterase I activity in heart. J Lipid Res (2007) 1.20
Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J (1997) 1.18
Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. Am J Physiol Endocrinol Metab (2004) 1.13
A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms. J Biol Chem (1998) 1.12
Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab (2004) 1.11
Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J Biol Chem (2006) 1.02
Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart. Curr Hypertens Rep (2003) 0.96
Induction of antioxidant gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species. Free Radic Biol Med (2006) 0.90
Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis (2004) 0.90
Assessment of skin carbonyl content as a noninvasive measure of biological age. Arch Biochem Biophys (2002) 0.84
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg (2009) 3.24
Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation (2005) 3.22
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest (2009) 2.80
Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev (2007) 2.67
Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation (2002) 2.61
Epidemic obesity and the metabolic syndrome. Circulation (2003) 2.53
Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest (2002) 2.53
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev (2011) 2.48
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem (2005) 2.44
The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab (2009) 2.39
Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res (2009) 2.38
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes (2007) 2.24
Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol (2007) 2.17
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem (2004) 2.16
Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation (2002) 2.14
Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension. Cardiology (2015) 2.09
The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res (2010) 1.94
The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids. J Biol Chem (2006) 1.94
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes (2002) 1.83
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J Mol Cell Cardiol (2006) 1.73
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Cardiovasc Res (2005) 1.70
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci Transl Med (2013) 1.69
Bioinformatic profiling of the transcriptional response of adult rat cardiomyocytes to distinct fatty acids. J Lipid Res (2008) 1.63
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation (2007) 1.59
Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation (2003) 1.56
Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension (2006) 1.56
Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation (2009) 1.55
Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy. Mol Cell Biol (2011) 1.55
Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol (2006) 1.52
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol (2004) 1.49
Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation (2009) 1.48
The intrinsic circadian clock within the cardiomyocyte. Am J Physiol Heart Circ Physiol (2005) 1.42
Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am J Physiol Heart Circ Physiol (2006) 1.41
Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery. Am J Med (2008) 1.39
O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock. J Biol Chem (2011) 1.36
Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology (2002) 1.33
Adaptation and maladaptation of the heart in obesity. Hypertension (2008) 1.29
Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol (2002) 1.27
Cardiac metabolism as a target for the treatment of heart failure. Circulation (2004) 1.27
Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem Biophys Res Commun (2006) 1.26
Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. J Biol Chem (2009) 1.24
Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation (2006) 1.21
Diabetes or peroxisome proliferator-activated receptor alpha agonist increases mitochondrial thioesterase I activity in heart. J Lipid Res (2007) 1.20
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis. Cardiology (2015) 1.19
Proposed regulation of gene expression by glucose in rodent heart. Gene Regul Syst Bio (2007) 1.18
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc (2013) 1.18
CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation (2007) 1.15
Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol (2007) 1.15
Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation (2002) 1.15
Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab (2005) 1.14
Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. Am J Physiol Endocrinol Metab (2004) 1.13
Switching metabolic genes to build a better heart. Circulation (2002) 1.13
Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction. Mol Cell Biol (2011) 1.13
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant (2004) 1.12
Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab (2004) 1.11
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart. Cardiovasc Res (2007) 1.11
Evidence suggesting that the cardiomyocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice. Chronobiol Int (2011) 1.10
Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy. Am J Physiol Heart Circ Physiol (2003) 1.10
Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats. Circ Res (2012) 1.10
Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun (2010) 1.10
In the footsteps of Virchow. JACC Cardiovasc Imaging (2014) 1.09
Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. Am J Clin Nutr (2006) 1.09
Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: a microarray gene expression profile. Diabetes (2003) 1.09
Slimming the heart with bariatric surgery. J Am Coll Cardiol (2013) 1.09
Nonischemic heart failure in diabetes mellitus. Curr Opin Cardiol (2008) 1.09
Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol (2005) 1.08
Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol (1985) (2012) 1.08
Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol (2009) 1.08
Perhexiline, Cardiac Energetics, and Heart Failure: Lessons From the First Law of Thermodynamics. JACC Heart Fail (2015) 1.08
Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med (2009) 1.08
Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res (2008) 1.08
Refugee cardiologists and the coexistence of the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2013) 1.07
Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation (2005) 1.07
Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J Lipid Res (2010) 1.04
Hypoxia-induced decrease of UCP3 gene expression in rat heart parallels metabolic gene switching but fails to affect mitochondrial respiratory coupling. Biochem Biophys Res Commun (2004) 1.02
Atrophic remodeling of the transplanted rat heart. Cardiology (2006) 1.02
Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. Am J Physiol Heart Circ Physiol (2007) 1.02
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. Am J Physiol Heart Circ Physiol (2003) 1.02
The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. Am J Physiol Heart Circ Physiol (2010) 1.01
Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am J Physiol Endocrinol Metab (2013) 1.01
Regulation of fatty acid metabolism by cell autonomous circadian clocks: time to fatten up on information? J Biol Chem (2011) 1.01
Glycogen in the heart--an expanded view. J Mol Cell Cardiol (2004) 1.01
Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med (2010) 1.01
Ménage-à-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1. Cell Metab (2007) 1.00
AMP-activated protein kinase regulates E3 ligases in rodent heart. Circ Res (2011) 0.99
Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo. J Nucl Med (2013) 0.99
Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet. Clin Exp Pharmacol Physiol (2007) 0.98
Taking pressure off the heart: the ins and outs of atrophic remodelling. Cardiovasc Res (2011) 0.98
Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart. Am J Physiol Heart Circ Physiol (2006) 0.98
Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ Res (2014) 0.98